Orion Healthcare Equity Partners
VC Fund
Boston, United States
Orion Healthcare Equity Partners is a VC fund in Boston focused on Health Care and Biotechnology. Orion Healthcare Equity Management is a Venture Capital Firm focussed on health. Orion invested in Solexa (genetic sequencing), acquired by Illumina for $600 million in 2007. Orion funded PowderMed (DNA vaccine delivery), purchased by Pfizer.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Orion Healthcare Equity Partners invests in
Stages Orion Healthcare Equity Partners invests in
Countries Orion Healthcare Equity Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bob Dean
|
|||
Daniel Wheeler L
|
|||
Mark Carthy
|
|||
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bob Dean
Advisor
|
Advisor | Total investments: 0 | Find email | |
|
Daniel Wheeler L
Advisor
|
Advisor | Total investments: 0 | Find email | |
|
Mark Carthy
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AnTolRx
|
At AnTolRx they are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include life threatening infections and tumors. Thus, there is an unmetclinical need for methods of targeted immune-regulation. Their proprietary drug development approach selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases. | $4M / Series A / Sep 08, 2016 |
Co-Investors
Breakthrough T1D
1 deal together
Pfizer Venture Investments
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Orion Healthcare Equity Partners invest in?
Orion Healthcare Equity Partners invests primarily in Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Orion Healthcare Equity Partners?
Public channels for Orion Healthcare Equity Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Orion Healthcare Equity Partners?
The team at Orion Healthcare Equity Partners includes Bob Dean (Advisor), Daniel Wheeler L (Advisor) and Mark Carthy (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
